Literature DB >> 12422338

Maximizing extraction of botulinum toxin type A from vials.

Dennis D Dykstra1, J Michael Wieting, John McGuire, Thomas Kowalkowski.   

Abstract

OBJECTIVES: To determine the residual botulinum toxin remaining in vials after using 3 different extraction methods and to analyze the different techniques for measuring extraction efficacy.
DESIGN: Multicentered comparative study.
SETTING: Three academic movement disorder clinics. PARTICIPANTS: Thirty physicians were randomly surveyed for their botulinum toxin extraction methods. Three physicians evaluated the most common methods.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: Amount of toxin left in vials after each extraction method.
RESULTS: Toxin was least successfully extracted by using the vial inversion method. More toxin was extracted by using the 2-in needle method. The top removal method produced the least waste of toxin but is considered unsafe.
CONCLUSIONS: The best and safest method for consistently extracting the most botulinum toxin from its vial was to use a long 21-gauge 2-in needle attached to a 3-mL syringe. Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422338     DOI: 10.1053/apmr.2002.34818

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  Neurotoxin waste from drawing product through the vial stopper.

Authors:  Joe Niamtu
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

Review 2.  Poststroke motor dysfunction and spasticity: novel pharmacological and physical treatment strategies.

Authors:  Stefan Hesse; Cordula Werner
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.

Authors:  Gerard E Francisco; Alexander Balbert; Ganesh Bavikatte; Djamel Bensmail; Stefano Carda; Thierry Deltombe; Nathalie Draulans; Steven Escaldi; Raphael Gross; Jorge Jacinto; Nicholas Ketchum; Franco Molteni; Susana Moraleda; Michael W ODell; Rajiv Reebye; Patrik Säterö; Monica Verduzco-Gutierrez; Heather Walker; Jörg Wissel
Journal:  J Rehabil Med       Date:  2021-01-01       Impact factor: 2.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.